An Open-Label Study to Assess Monthly Risperidone Injections (180 mg) Following Switch from Daily Oral Risperidone (6 mg) in Stable Schizophrenic Patients
Article in Clinical Drug Investigation (February 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Clinical Drug Investigation (February 2024)
Article in Expert Opinion on Drug Metabolism & Toxicology (April 2023)
Article in Clinical Pharmacology in Drug Development (March 2022)